The ASCO Abstracts Are Coming

The American Society for Clinical Oncology annual meeting doesn't start until the end of this month, but investors will get a little sneak peek of what to expect when abstracts for the meeting are released at 5 p.m. Eastern on Wednesday.

In the video below, senior biotech specialist Brian Orelli and health-care analyst David Williamson discuss what they're looking forward to seeing at ASCO, including AstraZeneca's (NYSE: AZN  ) phase 2 data for its PARP inhibitor olaparib used alone or in combination with cediranib in patients with ovarian cancer, Johnson & Johnson (NYSE: JNJ  ) and Pharmacyclics'  (NASDAQ: PCYC  ) phase 3 data testing Imbruvica verse GlaxoSmithKline's (NYSE: GSK  ) Arzerra in elderly CLL patient, Incyte's (NASDAQ: INCY  ) data on Jakafi in pancreatic cancer, and others.

Invest before it hits mainstream
Let's face it, every investor wants to get in on revolutionary ideas before they hit it big. Like buying PC-maker Dell in the late 1980s, before the consumer computing boom. Or purchasing stock in e-commerce pioneer Amazon.com in the late 1990s, when it was nothing more than an upstart online bookstore. The problem is, most investors don't understand the key to investing in hyper-growth markets. The real trick is to find a small-cap "pure-play" and then watch as it grows in EXPLOSIVE lockstep with its industry. Our expert team of equity analysts has identified one stock that's poised to produce rocket-ship returns with the next $14.4 TRILLION industry. Click here to get the full story in this eye-opening report.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2956269, ~/Articles/ArticleHandler.aspx, 8/29/2014 1:22:26 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement